Capitalbio: Biochips Based In Vitro Diagnostics (IVD) Solutions for Genetic Research

Instruments Consumbles Health Solutions

Working with microfluidic chips, it adopts multiple advanced technologies, and integrates nucleic acid extraction, nested isothermal amplification, and real-time fluorescence detection within one.

Instruments

Fully Integrated Platform for COVID-19

The perfect combination of microfluidic technology and isothermal amplification technology meets the current needs of high-throughput, economical, and efficient rapid testing in food safety, clinical diagnosis, and other fields.

Instruments

Microfluidic Platform

An ideal micro-environment for hydrodynamic and molecular thermodynamic hybridization reactions, and enhance reaction signals and improve consistency of results.

Instruments

Microarray Platform

CapitalBio®BioelectronSeq 4000 Sequencer: The system adopts semiconductor sequencing technology. Working with clinical testing kits, automated data analysis and management software, it is ideal for clinical laboratories.

CapitalBio®BioelectronSeq 4000 Sequencer

Instruments

Next Generation Sequencing Platforms

The platform integrates a series of operations such as biological sample loading, PCR reaction, fluorescence in situ detection, etc., to achieve high-throughput, flexible and accurate SNP/InDel detection.

Instruments

IMAP Platform

Offer individualized health care solutions to customers by utilizing cutting-edge technology.

Instruments

Smart Health Platform

A forensic DNA test using microfluidic technology can be conducted in two hours or less.

CapitalBio Quick TargSeq™ Fully Integrated Automatic On-site DNA Quick Test System

Instruments

Forensic Platform

CapitalBio® CalSlide-III Calibration Slide

It can be used to calibrate and maintain microarray fluorescence scanners and compare signal intensities. It's needed for microarray analysis and detection.

Consumbles

CapitalBio® CalSlide-III Calibration Slide

It is intended to hold a 25mm 75mm microarray slide in an isolated environment to prevent the hybridization solution from evaporating.

Consumbles

Hybridization Box

Solutions for Infectious Disease Control

CapitalBio provides comprehensive control solutions for infectious diseases, such as Respiratory Pathogens related diseases and Tuberculosis Bacteria related diseases, in order to assist clinicians in formulating precise diagnoses and treatment plans.

Health Solutions

Solutions for Infectious Disease Control

Solutions for Maternal and Child Healthcare

Based on the powerful testing platform and independent research and development capabilities, CapitalBio formed a congenital disability prevention and control program including NIPT, NIPT-PLUS, CNV-seq, and Deafness-related Gene Mutation detection, escort for the health of women and children.

Health Solutions

Solutions for Maternal and Child Healthcare

The new model of cancer diagnosis and treatment is genetic testing combined with targeted therapy, which will enhance both the effective rate and overall survival of cancer patients. CapitalBio anti-cancer solutions cover all stages of cancer development, from diagnosis to treatment to prognosis.

Health Solutions

Solutions for Anti-cancer Therapy

Based on pharmacogenomics, Pharmacogenomics Testing makes prescription safer and more effective by detecting genes associated with drug metabolism, efficacy, and side effects. Given the stability of genes and the irreversibility of the impact of many ADRs, the test would benefit the entire life.